Zachery Roger Reichert, MD, PhD, discusses key research questions to explore in early-stage prostate cancer.
Zachery Roger Reichert, MD, PhD
Advertisement
Articles by Zachery Roger Reichert, MD, PhD
Zachery Roger Reichert, MD, PhD, discusses the effects novel agents and pathways have had on the treatment of patients with prostate cancer.
Zachery Roger Reichert, MD, PhD, discusses novel agents and pathways under exploration in prostate cancer.
Advertisement
Latest Updated Articles
Dr Reichert on Investigating Novel Agents and Pathways in Prostate CancerPublished: August 23rd 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5